287 523

Cited 17 times in

Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer

DC Field Value Language
dc.contributor.author김경환-
dc.contributor.author김창곤-
dc.contributor.author김혜련-
dc.contributor.author박성용-
dc.contributor.author심효섭-
dc.contributor.author윤홍인-
dc.date.accessioned2022-02-23T01:21:15Z-
dc.date.available2022-02-23T01:21:15Z-
dc.date.issued2021-10-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/187651-
dc.description.abstractBackground: Reinvigoration of T-cell exhaustion with antibodies has shown promising efficacy in patients with non-small-cell lung cancer (NSCLC). However, the characteristics of T-cell exhaustion with regard to tumor-infiltrating lymphocytes (TILs) are poorly elucidated in NSCLC. Here, we investigated the exhaustion status of TILs in NSCLC patients at the intraindividual and interindividual levels. Methods: We obtained paired peripheral blood, normal adjacent tissues, peritumoral tissues, and tumor tissues from 96 NSCLC patients. Features of T-cell exhaustion were analyzed by flow cytometry. T cells were categorized according to their programmed cell death-1 (PD-1) expression (PD-1high, PD-1int, and PD-1neg cells). Patients were classified based on the presence or absence of discrete PD-1high CD8+ TILs. Production of effector cytokines by CD8+ TILs was measured after T-cell stimulation with or without antibodies against immune checkpoint receptors. Results: Progressive T-cell exhaustion with marked expression of exhaustion-related markers and diminished production of effector cytokines was observed in PD-1high CD8+ TILs compared with PD-1int and PD-1neg CD8+ TILs. Patients with distinct PD-1high CD8+ TILs (PD-1high expressers) exhibited characteristics associated with a favorable anti-PD-1 response compared with those without these lymphocytes (non-PD-1high expressers). Combined inhibition of dual immune checkpoint receptors further restored effector cytokine production by CD8+ TILs following T-cell stimulation. PD-1high CD8+ T lymphocyte populations in the peripheral blood and tumors were significantly correlated. Conclusions: T-cell exhaustion was differentially regulated among individual patients and was prominent in a subgroup of NSCLC patients who may benefit from PD-1 blockade or combined blockade of other immune checkpoint receptors.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherBioMed Central-
dc.relation.isPartOfJOURNAL FOR IMMUNOTHERAPY OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleDistinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.googleauthorChang Gon Kim-
dc.contributor.googleauthorGamin Kim-
dc.contributor.googleauthorKyung Hwan Kim-
dc.contributor.googleauthorSeyeon Park-
dc.contributor.googleauthorSunhye Shin-
dc.contributor.googleauthorDahee Yeo-
dc.contributor.googleauthorHyo Sup Shim-
dc.contributor.googleauthorHong In Yoon-
dc.contributor.googleauthorSeong Yong Park-
dc.contributor.googleauthorSang-Jun Ha-
dc.contributor.googleauthorHye Ryun Kim-
dc.identifier.doi10.1136/jitc-2021-002780-
dc.contributor.localIdA05226-
dc.contributor.localIdA05991-
dc.contributor.localIdA01166-
dc.contributor.localIdA01508-
dc.contributor.localIdA02219-
dc.contributor.localIdA04777-
dc.relation.journalcodeJ03617-
dc.identifier.pmid34907028-
dc.subject.keywordlung neoplasms-
dc.subject.keywordlymphocytes-
dc.subject.keywordprogrammed cell death 1 receptor-
dc.subject.keywordtumor microenvironment-
dc.subject.keywordtumor-infiltrating-
dc.contributor.alternativeNameKim, Kyung Hwan-
dc.contributor.affiliatedAuthor김경환-
dc.contributor.affiliatedAuthor김창곤-
dc.contributor.affiliatedAuthor김혜련-
dc.contributor.affiliatedAuthor박성용-
dc.contributor.affiliatedAuthor심효섭-
dc.contributor.affiliatedAuthor윤홍인-
dc.citation.volume9-
dc.citation.number12-
dc.citation.startPagee002780-
dc.identifier.bibliographicCitationJOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol.9(12) : e002780, 2021-10-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Thoracic and Cardiovascular Surgery (흉부외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.